Search results
Results from the WOW.Com Content Network
Selumetinib (INN), [13] sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis type I (NF-1), a genetic disorder of the nervous system causing tumors to grow on nerves. [14] It is taken by mouth. [8]
Juvenile myelomonocytic leukemia (JMML) is a rare form of chronic leukemia (cancer of the blood) that affects children, commonly those aged four and younger. [2] The name JMML now encompasses all diagnoses formerly referred to as juvenile chronic myeloid leukemia (JCML), chronic myelomonocytic leukemia of infancy, and infantile monosomy 7 syndrome.
Childhood AML treatment usually consists higher dose chemotherapy given over a shorter period of time compared to ALL treatment. Due to this shorter and more intense treatment, side effects are also more intense. These children are therefore treated in treatment centers or hospitals where they will stay for longer period of their treatment.
Common side effects when applied as a cream include rash, redness, and burning. [4] Side effects of the injectable form include bone marrow suppression, vomiting, and seizures. [5] It is unclear if it is safe to use during pregnancy or breastfeeding. [5] It is recommended typically for children over the age of 12. [5]
Nausea and vomiting are two of the most feared cancer treatment-related side-effects for people with cancer and their families. In 1983, Coates et al. found that people receiving chemotherapy ranked nausea and vomiting as the first and second most severe side-effects, respectively. [98]
On today's episode of Good Word with Goodwill, Vincent Goodwill is joined by former NBA video coordinator, turned contributor for The Athletic and Bleacher Report Mo Dakhil.
All treatments for CNS tumors have significant risks and side-effects. In cases where tumors are slow growing and do not cause symptoms, it may be preferable to closely watch the patient's condition without any treatment, until new test results or symptoms indicate that the patient's condition has worsened.
The electric vehicle market could get a huge influx of cheaper cars — but not fresh from the factory. In its latest EV intelligence report, consumer research firm J.D. Power projects that a ...